Surabhi Pathak
Hematology & Oncology Physician in Ashland, Kentucky.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,215 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Surabhi Pathak filed 926 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in Ashland, Kentucky, prescribing 85% generic.
- 926
- Part D claims, 2023
- 85%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Surabhi Pathak's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
926 Top 25% higher than 75% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
Surabhi Pathak practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Surabhi Pathak?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Kentucky
How Hematology & Oncology Physician compares to other specialties among Kentucky providers
Hematology & Oncology Physician ranks #75 among Kentucky's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Kentucky provider total, by primary NUCC taxonomy. The highlighted bar is Hematology & Oncology Physician; the long tail of smaller specialties is omitted for legibility.
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Surabhi Pathak appears in the CMS NPPES registry as a Hematology & Oncology Physician provider at 613 23RD ST STE 19, Ashland, KY, 41101, with a listed phone of (606) 325-2221. NPI 1285999284 was issued on 07/06/2012.
Medicare Part D records for calendar year 2023 show 926 prescription claims written by this provider, covering 183 Medicare beneficiaries and totaling roughly $1.3 million in drug spend, split 15% brand-name and 85% generic by claim count, with an opioid prescribing rate of 15.7%.
Hematology & Oncology Physician is a mid-sized specialty nationwide, with 11,215 enrolled providers across 54 states and an average of 847 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1285999284 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Gender | Female |
| NPI Issued | 07/06/2012 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Surabhi Pathak's current license status, disciplinary history, and board certifications with the Kentucky Board of Medical Licensure in Kentucky before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1285999284 is the unique 10-digit identifier CMS uses to link Pathak across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
Hospital and facility affiliations
Facilities where Surabhi Pathak bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Surabhi Pathak. Source: openpaymentsdata.cms.gov.
Total received
$453
Largest payer
Novartis Pharmaceuticals Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
15% brand-name claims vs 85% generic, on 926 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 1,110
- Total Day Supply
- 27,622
- Brand vs Generic
- 15% brand / 85% generic
- Brand Drug Cost
- $1.3M
- Generic Drug Cost
- $21K
- Opioid Claims
- 145 (15.7% rate)
- Antibiotic Claims
- 45
Patient Demographics
- Average Patient Age
- 70.5 years
- Avg HCC Risk Score
- 2.44
- Gender Split
- 68% female / 32% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Surabhi Pathak prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anastrozole
Anastrozole
131 claims
- Oxycodone-Acetamin…
Oxycodone-Acetaminophen
75 claims
- Ondansetron Hcl
Ondansetron Hcl
62 claims
- Lidocaine-Prilocaine 43
Lidocaine-Prilocaine
43 claims
- Prochlorperazine M… 41
Prochlorperazine Maleate
41 claims
- Potassium Chloride 38
Potassium Chloride
38 claims
- Gabapentin 32
Gabapentin
32 claims
- Exemestane 22
Exemestane
22 claims
| Drug | Claims |
|---|---|
| Anastrozole | 131 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 75 |
| Ondansetron Hcl | 62 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 43 |
| Prochlorperazine Maleate | 41 |
| Potassium Chloride | 38 |
| Gabapentin | 32 |
| Exemestane | 22 |
| Mekinist Trametinib Dimethyl Sulfoxide | 21 |
| Lorazepam | 19 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Surabhi Pathak fits within the Hematology & Oncology Physician landscape nationally.
Surabhi Pathak's 926 claims are above the specialty average of 847.
Nearby Hematology & Oncology Physician Providers in Kentucky
Other clinicians with the same primary specialty enrolled in Kentucky, drawn from the same CMS NPPES roster as Pathak.
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Kentucky medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Hematology & Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Kentucky
Frequently Asked Questions
What is Surabhi Pathak's specialty? ▼
How much does Surabhi Pathak prescribe under Medicare Part D? ▼
Where is Surabhi Pathak located? ▼
What is Surabhi Pathak's NPI number? ▼
Does Surabhi Pathak prescribe more brand-name or generic drugs? ▼
Does Surabhi Pathak prescribe opioids? ▼
How many Hematology & Oncology Physician providers are there in the US? ▼
What drugs does Surabhi Pathak prescribe most often? ▼
Does Surabhi Pathak accept Medicare? ▼
How can I verify Surabhi Pathak's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology